Effect of neotetrazolium on sympathetic ganglionic transmission.
D000200:Action Potentials / Q000187:drug effects; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001338:Autonomic Fibers, Postganglionic / Q000187:drug effects; D001339:Autonomic Fibers, Preganglionic / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects*; D005730:Ganglionic Blockers / Q000494:pharmacology; D008297:Male; D011817:Rabbits; D009435:Synaptic Transmission / Q000187:drug effects*; D013778:Tetrazolium Salts / Q000494:pharmacology*; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D013778:Tetrazolium Salts; D000804:Angiotensin II